Homeopathy 2016; 105(03): 265-269
DOI: 10.1016/j.homp.2016.04.003
Original Paper
Copyright © The Faculty of Homeopathy 2016

In vitro assessment of anticytotoxic and antigenotoxic effects of CANOVA®

Authors

  • Henrique Fonseca Sousa do Nascimento

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Plínio Cerqueira dos Santos Cardoso

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Helem Ferreira Ribeiro

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Tatiane Cristina Mota

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Lorena Monteiro Gomes

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • André Salim Khayat

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Adriana Costa Guimarães

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Marucia Irena Medeiros Amorim

    2   Universidade da Amazônia (UNAMA), Belém, Pará, Brazil
  • Rommel Rodriguéz Burbano

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Marcelo de Oliveira Bahia

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
Further Information

Publication History

Received08 April 2015
revised20 February 2016

accepted29 February 2016

Publication Date:
28 December 2017 (online)

Background: CANOVA® (CA) is a homeopathic immunomodulator. It contains several homeopathic medicines prepares according to the Brazilian Pharmacopoeia. CA is indicated in clinical conditions in which the immune system is impaired and against tumors. N-methyl-N-nitrosourea (NMU) is an N-nitroso compound, with genotoxic/mutagenic properties. Although several studies have shown promising results in the use of CA, there are no studies reporting possible antigenotoxic effects.

Method: This study evaluated the in vitro antigenotoxic and anticytotoxic effects of CA in human lymphocytes exposed to NMU. Samples of human lymphocytes that were subjected to different concentrations of a mixture containing CA and NMU were used. The genotoxicity/antigenotoxicity of CA was evaluated by the comet assay, anticytotoxicity was assessed by quantification of apoptosis and necrosis using acridine orange/ethidium bromide.

Results: CA significantly reduced DNA damage induced by NMU and reduced significantly the frequency of NMU-induced apoptosis after 24 h of treatment.

Conclusion: CA has an important cytoprotective effect significantly reducing the DNA damage and apoptosis induced by the carcinogen NMU.